ARTICLE | Company News
IMGN up on extended deal
September 1, 2005 12:58 AM UTC
ImmunoGen (IMGN) gained $0.42 to $6.35 on Wednesday after sanofi-aventis (Euronext:SAN; SNY) extended for one year a 2003 deal to co-develop cancer antibodies using targets from both companies. SAN wi...